You have 9 free searches left this month | for more free features.

DREAMM 13

Showing 76 - 100 of 2,839

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autism Spectrum Disorder (ASD) Trial in Australia, New Zealand, United States (AB-2004, Placebo)

Recruiting
  • Autism Spectrum Disorder (ASD)
  • Phoenix, Arizona
  • +22 more
Aug 16, 2022

Ventral Hernia, Umbilical Hernia, Ventral Incisional Hernia Trial in Ghent (Hernia repair)

Not yet recruiting
  • Ventral Hernia
  • +2 more
  • Hernia repair
  • Ghent, Belgium
    AZ Maria Middelares
Oct 8, 2022

Contraception Trial in Móstoles (LVDS)

Recruiting
  • Contraception
  • LVDS
  • Móstoles, Madrid, Spain
    LR-301/
Aug 30, 2023

Safety and Tolerability Trial in Neuss (ZP7570, Placebo)

Not yet recruiting
  • Safety and Tolerability
  • Neuss, North Rhine-Westphalia, Germany
    Profil Institut für Stoffwechselforschung GmbH
Aug 18, 2023

Acute Coronary Syndrome Trial (AZD5718, Placebo)

Recruiting
  • Acute Coronary Syndrome
  • Cairns, Australia
  • +9 more
Dec 13, 2022

Beta-Thalassemia Trial in Bulgaria, Israel, United States (VIT-2763 60 mg QD, VIT-2763 60 mg BID, VIT-2763 120 mg BID)

Withdrawn
  • Beta-Thalassemia
  • VIT-2763 60 mg QD
  • +3 more
  • Whittier, California
  • +6 more
Nov 7, 2022

Discharge After Cesarean Section

Completed
  • Early Discharge of Patients After Cesarean Section
  • KATZ index of independence in activities of daily living
  • Cairo, Egypt
    AinShams university maternity hospital
Jan 7, 2023

Hypertension Trial (Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs)

Not yet recruiting
  • Hypertension
  • Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs
  • (no location specified)
Mar 21, 2023

Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed Multiple Myeloma
  • Belantamab mafodotin
  • +2 more
  • Badalona, Spain
  • +14 more
Sep 5, 2022

Physiotherapy in Critically Ill Covid Patients

Recruiting
  • COVID-19
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Sep 14, 2023

    Multiple Myeloma, Complication Trial in Lyon (Interpretation of the results from the detection visit, Explaining detection

    Not yet recruiting
    • Multiple Myeloma
    • Complication
    • Interpretation of the results from the detection visit
    • +3 more
    • Lyon, France
      Centre Léon Bérard
    Jul 7, 2023

    Painful Diabetic Neuropathy Trial (NRD135SE.1, Placebo)

    Not yet recruiting
    • Painful Diabetic Neuropathy
    • (no location specified)
    Aug 15, 2022

    Healthy Volunteers (Meningococcal Infection) Trial in Puerto Rico, United States (Meningococcal Polysaccharide (Serogroups A,C,Y

    Recruiting
    • Healthy Volunteers (Meningococcal Infection)
    • Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine
    • +10 more
    • Birmingham, Alabama
    • +50 more
    Jan 4, 2023

    Fabry Disease Trial (PRX-102 1 mg/kg every 2 weeks, PRX-102 2 mg/kg every 4 weeks)

    Not yet recruiting
    • Fabry Disease
    • PRX-102 1 mg/kg every 2 weeks
    • PRX-102 2 mg/kg every 4 weeks
    • (no location specified)
    Jan 24, 2023

    Scapular Dyskinesis, Pectoralis Minor Syndrome Trial in Faisalabad (stabilization exercises, stabilization exercises along with

    Recruiting
    • Scapular Dyskinesis
    • Pectoralis Minor Syndrome
    • stabilization exercises
    • stabilization exercises along with pectoralis minor stretching
    • Faisalābad, Punjab, Pakistan
      Al fatah sport complex
    Nov 9, 2023

    Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

    Recruiting
    • Retinitis Pigmentosa
    • +7 more
    • San Diego, California
    • +14 more
    Jul 29, 2022

    Prostate Cancer, Advanced Prostate Carcinoma Trial in San Francisco (Hyperpolarized C13, Magnetic Resonance Imaging (MRI))

    Recruiting
    • Prostate Cancer
    • Advanced Prostate Carcinoma
    • Hyperpolarized C13
    • Magnetic Resonance Imaging (MRI)
    • San Francisco, California
      University of California, San Francisco
    Jul 27, 2022

    Osteoarthritis of the Knee Trial in Czechia, Hungary, Poland (Cingal)

    Completed
    • Osteoarthritis of the Knee
    • Cingal
    • Uherske Hradiste, Czechia
    • +9 more
    Feb 23, 2022

    Bias, Implicit Trial in Medellin (Self-administered survey, Enumerator-administered survey)

    Recruiting
    • Bias, Implicit
    • Self-administered survey
    • Enumerator-administered survey
    • Medellin, Antioquia, Colombia
      Innovations for Poverty Action
    Oct 31, 2022

    Urinary Tract Infections Trial (Gepotidacin, Nitrofurantoin, Placebo)

    Not yet recruiting
    • Urinary Tract Infections
    • (no location specified)
    Dec 9, 2022

    (SNPs) in Metalloproteinases Genes With Risk of Primary Knee

    Recruiting
    • Metalloproteinase SNPs -1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13 and Risk for Developing Knee Osteoarthritis in Greek Population
    • No intervention, Patients selection based on clinical symptoms and radiological imaging
    • Thessaloníki, Athens, Greece
      3rd Orthopedic Department , Pagageorgiou Hospital
    Aug 17, 2022

    Traditional Strength Training vs Inertial Training Trial in Zielona Góra (Inertial training, Body building training)

    Completed
    • Traditional Strength Training vs Inertial Training
    • Inertial training
    • Body building training
    • Zielona Góra, Poland
      University of Zielona Gora
    Dec 20, 2022

    Signs and Symptoms, Digestive Trial in Valinhos (Probiatop, Placebo)

    Recruiting
    • Signs and Symptoms, Digestive
    • Valinhos, São Paulo, Brazil
      A2Z Clinical Centro Avancado de Pesquisa Clinica Eireli
    Oct 31, 2022

    Bowel Disease Trial in Fukuoka, Osaka, Tokyo (NPO-13)

    Completed
    • Bowel Disease
    • Fukuoka, Japan
    • +2 more
    Nov 15, 2021

    Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Ibrutinib and obinutuzumab
    • Milano, MI, Italy
      Strategic Research Program on CLL
    Apr 2, 2022